| 000 | 01750 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517042523.0 | ||
| 264 | 0 | _c20160912 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.12723 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeumer, Jan H | |
| 245 | 0 | 0 |
_aHuman hepatocyte assessment of imatinib drug-drug interactions - complexities in clinical translation. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cNov 2015 |
||
| 300 |
_a1097-108 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzoxazines _xpharmacology |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A Inducers _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatocytes _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xmetabolism |
| 650 | 0 | 4 |
_aKetoconazole _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aRitonavir _xpharmacology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPillai, Venkateswaran C | |
| 700 | 1 | _aParise, Robert A | |
| 700 | 1 | _aChristner, Susan M | |
| 700 | 1 | _aKiesel, Brian F | |
| 700 | 1 | _aRudek, Michelle A | |
| 700 | 1 | _aVenkataramanan, Raman | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 80 _gno. 5 _gp. 1097-108 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.12723 _zAvailable from publisher's website |
| 999 |
_c25078173 _d25078173 |
||